Use of SBRT in Treating Pancreatic Cancer
Hoffe also highlights a recent study published in Lancet Oncology using a genomic-adjusted radiation dose (GARD) in patients with various malignancies, a method that could individualize radiotherapy treatment. Watch here . . .